George Diaz, M.D., Ph.D., is VP, Therapeutic Area Lead for Urea Cycle Disorders (UCDs) at iECURE. Dr. Diaz has more than 25 years of experience in genetics and pediatrics, particularly in metabolic diseases. As Chief of the Division of Medical Genetics and Genomics at the Icahn School of Medicine at Mount Sinai in New York, he has collaborated extensively with industry partners to bring novel therapeutics to patients with UCDs and other rare genetic disorders.